Morning Market Gainers

shares jumped 42.39 percent to $4.77 after the company reported that its Phase 3 clinical trial design for EVK-001 is consistent with the FDA's draft guidance.

shares surged 29.18 percent to $4.25. Versar reported a Q4 loss of $0.10 per share on sales of $56.3 million.

shares rose 12.53 percent to $120.29 after the company reported positive proof of concept data in schizophrenia.

climbed 9.44 percent to $5.68. NetSol reported a Q4 loss of $0.07 per share on revenue of $15.4 million.

gained 4.07 percent to $33.30. Piper Jaffray's Erinn E. Murphy reiterated an Overweight rating and price target of $60 on Fitbit. Cleveland Research initiated coverage on Fitbit with a Neutral rating and a $38.00 price target.

shares rose 3.15 percent to $12.11 after the company agreed to acquire all of the television and radio stations of Schurz Communications, Inc. for around $442.5 million.

shares gained 4.15 percent to $39.15. Analysts at Morgan Stanley initiated coverage of DBV Technologies with a Overweight rating.

shares gained 3 percent to $68.83 after surging 3.76 percent on Monday.

surged 1.86 percent to $33.49 after rising 1.42 percent on Monday.